The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication

Q Ning, D Wu, X Wang, D Xi, T Chen, G Chen… - Signal transduction and …, 2022 - nature.com
Abstract The coronavirus disease 2019 (COVID-19) is a highly transmissible disease
caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that poses a …

The role of epithelial damage in the pulmonary immune response

RA Burgoyne, AJ Fisher, LA Borthwick - Cells, 2021 - mdpi.com
Pulmonary epithelial cells are widely considered to be the first line of defence in the lung
and are responsible for coordinating the innate immune response to injury and subsequent …

Tolerability and immunogenicity of an intranasally-administered adenovirus-vectored COVID-19 vaccine: An open-label partially-randomised ascending dose phase I …

M Madhavan, AJ Ritchie, J Aboagye, D Jenkin… - …, 2022 - thelancet.com
Background Intranasal vaccination may induce protective local and systemic immune
responses against respiratory pathogens. A number of intranasal SARS-CoV-2 vaccine …

The altered entry pathway and antigenic distance of the SARS-CoV-2 Omicron variant map to separate domains of spike protein

TP Peacock, JC Brown, J Zhou, N Thakur, K Sukhova… - biorxiv, 2022 - biorxiv.org
At the end of 2021 a new SARS-CoV-2 variant, Omicron, emerged and quickly spread
across the world. It has been demonstrated that Omicron's high number of Spike mutations …

Human airway and nasal organoids reveal escalating replicative fitness of SARS-CoV-2 emerging variants

C Li, J Huang, Y Yu, Z Wan, MC Chiu… - Proceedings of the …, 2023 - National Acad Sciences
The high transmissibility of SARS-CoV-2 Omicron subvariants was generally ascribed to
immune escape. It remained unclear whether the emerging variants have gradually …

Viral emissions into the air and environment after SARS-CoV-2 human challenge: a phase 1, open label, first-in-human study

J Zhou, A Singanayagam, N Goonawardane… - The Lancet …, 2023 - thelancet.com
Background Effectively implementing strategies to curb SARS-CoV-2 transmission requires
understanding who is contagious and when. Although viral load on upper respiratory swabs …

Divalent siRNAs are bioavailable in the lung and efficiently block SARS-CoV-2 infection

VN Hariharan, M Shin, CW Chang… - Proceedings of the …, 2023 - National Acad Sciences
The continuous evolution of SARS-CoV-2 variants complicates efforts to combat the ongoing
pandemic, underscoring the need for a dynamic platform for the rapid development of pan …

Cell deaths: Involvement in the pathogenesis and intervention therapy of COVID-19

X Li, Z Zhang, Z Wang… - Signal transduction and …, 2022 - nature.com
The current pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has dramatically influenced …

Systems analysis shows that thermodynamic physiological and pharmacological fundamentals drive COVID‐19 and response to treatment

RJ Head, ER Lumbers, B Jarrott… - Pharmacology …, 2022 - Wiley Online Library
Why a systems analysis view of this pandemic? The current pandemic has inflicted almost
unimaginable grief, sorrow, loss, and terror at a global scale. One of the great ironies with …

Interferon‐induced transmembrane protein 3 (IFITM3) limits lethality of SARS‐CoV‐2 in mice

AD Kenney, A Zani, J Kawahara, AC Eddy, XL Wang… - EMBO …, 2023 - embopress.org
Interferon‐induced transmembrane protein 3 (IFITM3) is an antiviral protein that alters cell
membranes to block fusion of viruses. Conflicting reports identified opposing effects of …